Annexin A2 as a target endothelial cell membrane autoantigen in Behçet's disease

Peng Chen,Hai Yan,Yaping Tian,Yiping Xun,Lili Shi,Ran Bao,Huai Zhang,Guangyu Chen,Chunhe Yang,Shutao Sun,Yajie Wang,Li Liu,Yabin Zhou,Chunyan Zhang,Xiaoxu Wang,Yongqiang Wen,Yongzhong Bian,Hongwu Du
DOI: https://doi.org/10.1038/srep08162
IF: 4.6
2015-01-01
Scientific Reports
Abstract:Cell membrane proteins are believed to play a critical role in the pathogenesis of autoimmune diseases. However, few membrane autoantigens have been linked with Behçet's disease. Here, a cell-chip was performed to identify autoantibody target cells and the suspected autoantigens were detected using immunoblotting. The amino acid sequences of the detected proteins were determined using LC-MALDI-TOF/TOF. Putative proteins were recombinantly expressed and purified and a corresponding ELISA was developed and clinically validated using real clinical samples. It was found that a 36-kDa membrane protein - annexin A2 - was detected in approximately one-third of the patients' blood circulation. The immunohistochemistry results showed that annexin A2 was highly expressed in vascular endothelial cells. Moreover, vascular involvement was significantly higher in the anti-annexin A2 antibody-positive group versus the anti-annexin A2 antibody-negative group among all the clinical samples analyzed, indicating that annexin A2 is a novel endothelial cell membrane antigen involved in Behçet's disease.
What problem does this paper attempt to address?